Applications, hearings, determinations, etc.: Noramco, Inc.,

[Federal Register: May 25, 1999 (Volume 64, Number 100)]

[Notices]

[Page 28214]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr25my99-104]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 2, 1999, Noramco, Inc., 1400 Olympic Drive, Athens, Georgia 30601, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Codeine (9050)............................. II Oxycodone (9143)........................... II Hydrocodone (9193)......................... II Morphine (9300)............................ II Thebaine (9333)............................ II

The firm plans to support its other manufacturing facility with manufacturing and analytical testing.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than July 26, 1999.

Dated: May 12, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 99-13095Filed5-24-99; 8:45 am]

BILLING CODE 4410-09-M